Apixaban-Mepha 5 mg, Filmtabletten - 56 Swissmedic Key 69168005 Registration Holder Mepha Pharma AG Name Apixaban-Mepha 5 mg, Filmtabletten Date of registration 07.06.2023 Introduction of Sequence 07.06.2023 ATC-Classification Apixaban (B01AF02) Revision date WHO WHO-DDD Valid until 06.06.2028 Index Therapeuticus (BSV) Show package size 56 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680691680052 Medication Code Synthetika Pharmacode Disponibility
Composition apixabanum 5.0 mg, lactosum, cellulosum microcristallinum, carmellosum natricum conexum, natrii laurilsulfas, magnesii stearas, Überzug: lactosum monohydricum, hypromellosum, E 171, triacetinum, E 172 (rubrum), pro compresso obducto corresp. natrium 0.88 mg, lactosum 103.54 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Apixabanum 5 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Lactosum 103.54 mg Lactose Monohydrate Überzug Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto Triacetinum
Source Data was imported : 07.07.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
